[{"Assets_0_Q2_USD":39042861.0,"CommonStockSharesOutstanding_0_Q2_shares":23608084.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-13733020.0,"NetIncomeLoss_2_Q2_USD":-15079355.0,"NetIncomeLoss_1_Q2_USD":-7084316.0,"StockholdersEquity_0_Q2_USD":22754608.0,"Ticker":"AXSM","CIK":"1579428","name":"AXSOME THERAPEUTICS, INC.","OfficialName":"Axsome Therapeutics Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574461367.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]